Unique ID issued by UMIN | UMIN000024186 |
---|---|
Receipt number | R000027846 |
Scientific Title | Dose-ranging study to evaluate efficacy of single administration of amino acid mixture combined with exercise on fat metabolism in overweight adults |
Date of disclosure of the study information | 2016/09/27 |
Last modified on | 2016/09/27 14:31:12 |
Dose-ranging study to evaluate efficacy of single administration of amino acid mixture combined with exercise on fat metabolism in overweight adults
Dose-ranging study of amino acid mixture with single administration
Dose-ranging study to evaluate efficacy of single administration of amino acid mixture combined with exercise on fat metabolism in overweight adults
Dose-ranging study of amino acid mixture with single administration
Japan |
Overweight
Medicine in general | Endocrinology and Metabolism | Adult |
Others
NO
To examine the efficacy and effective dose of amino acid mixture on fat metabolism during exercise
Efficacy
Exploratory
Explanatory
Phase II
Blood ketone bodies level
Blood glycerol level
Blood free fatty acid level
Blood amino acids level
Blood triglyceride level
Blood glucose level
Blood lactic acid level
Blood adrenaline level
Blood noradrenaline level
Blood insulin level
Blood glucagon level
heart rate
beats per minute
questionnaire
Interventional
Cross-over
Randomized
Individual
Double blind -all involved are blinded
Placebo
YES
NO
Institution is not considered as adjustment factor.
NO
Central registration
4
Prevention
Food |
Dose1-wash out-Dose2-wash out-Dose3-wash out-placebo
Dose2-wash out-placebo-wash out-Dose1-wash out-Dose3
Dose3-wash out-Dose1-wash out-placebo-wash out-Dose2
placebo-wash out-Dose3-wash out-Dose2-wash out-Dose1
30 | years-old | <= |
50 | years-old | > |
Male
1) Subjects giving written informed consent
2) Men 30 to 65 years age and/or whose BMI of 25 to 30 kg/m^2
3) Men who has no regular exercise (more than two times a week/30 minutes or more in one year)
1) Sever systemic diseases
2) Subjects who drink a lot of alcohol
3) Smoker
4) Subjects whose eating habits are extremely irregulae (ex. midnight and irregulae shift worker)
5) Constant use of oral medication or supplements affecting body fat
6) Subjects who donated blood within 3 months before starting of administration.
7) Phenylketonuria, and hyperphenylalaninemia
8) Subjects who has food allergy
9) Subjects who are judged as unsuitable for the study by the investigator for other reason
16
1st name | |
Middle name | |
Last name | Katsuhisa Sakano |
CPCC Company Limited
Clinical Research Planning Department
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5297-3112
k.s@cpcc.co.jp
1st name | |
Middle name | |
Last name | Makoto Ichinohe |
CPCC Company Limited
Plan Sales Department
4F Chushin Build. 3-3-5 Uchikanda Chiyoda-ku, Tokyo 101-0047 Japan
03-5297-3112
m.i@cpcc.co.jp
CPCC Company Limited
Food Science Research Laboratories, Meiji Co., Ltd.
Profit organization
NO
2016 | Year | 09 | Month | 27 | Day |
Unpublished
Completed
2015 | Year | 11 | Month | 30 | Day |
2015 | Year | 12 | Month | 12 | Day |
2016 | Year | 09 | Month | 27 | Day |
2016 | Year | 09 | Month | 27 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027846